ATE457359T1 - Auf lps-reagierendes chs1/beige-ähnliches anker- gen und therapeutische anwendungen davon - Google Patents

Auf lps-reagierendes chs1/beige-ähnliches anker- gen und therapeutische anwendungen davon

Info

Publication number
ATE457359T1
ATE457359T1 AT02731226T AT02731226T ATE457359T1 AT E457359 T1 ATE457359 T1 AT E457359T1 AT 02731226 T AT02731226 T AT 02731226T AT 02731226 T AT02731226 T AT 02731226T AT E457359 T1 ATE457359 T1 AT E457359T1
Authority
AT
Austria
Prior art keywords
lrba
beige
responsive
gene
lps
Prior art date
Application number
AT02731226T
Other languages
English (en)
Inventor
William Kerr
Jia-Wang Wang
Original Assignee
Univ South Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ South Florida filed Critical Univ South Florida
Application granted granted Critical
Publication of ATE457359T1 publication Critical patent/ATE457359T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT02731226T 2001-04-02 2002-04-02 Auf lps-reagierendes chs1/beige-ähnliches anker- gen und therapeutische anwendungen davon ATE457359T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28010701P 2001-04-02 2001-04-02
PCT/US2002/010350 WO2002078614A2 (en) 2001-04-02 2002-04-02 Lps-responsive chs1/beige-like anchor gene and therapeutic applications thereof

Publications (1)

Publication Number Publication Date
ATE457359T1 true ATE457359T1 (de) 2010-02-15

Family

ID=23071704

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02731226T ATE457359T1 (de) 2001-04-02 2002-04-02 Auf lps-reagierendes chs1/beige-ähnliches anker- gen und therapeutische anwendungen davon

Country Status (7)

Country Link
US (2) US7704963B2 (de)
EP (1) EP1383924B1 (de)
AT (1) ATE457359T1 (de)
AU (1) AU2002303214A1 (de)
CA (1) CA2443338A1 (de)
DE (1) DE60235297D1 (de)
WO (1) WO2002078614A2 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020165192A1 (en) * 2000-09-19 2002-11-07 Kerr William G. Control of NK cell function and survival by modulation of ship activity
US7691821B2 (en) * 2001-09-19 2010-04-06 University Of South Florida Inhibition of SHIP to enhance stem cell harvest and transplantation
CA2443338A1 (en) * 2001-04-02 2002-10-10 University Of South Florida Lps-responsive chs1/beige-like anchor gene and therapeutic applications thereof
US8440395B2 (en) 2001-04-02 2013-05-14 University Of South Florida Methods of detecting and treating colon disorders
DE10229872A1 (de) * 2002-07-03 2004-01-29 Curevac Gmbh Immunstimulation durch chemisch modifizierte RNA
US20070224124A1 (en) * 2002-09-30 2007-09-27 University Of South Florida Novel SH2containing inositol 5'-phosphatase isoform that partners with the Grb2 adapter protein
AU2003263607A1 (en) * 2002-10-25 2004-05-13 Japan As Represented By The President Of The University Of Tokyo Method for diagnosing diffuse-type gastric cancer
US7807646B1 (en) 2003-11-20 2010-10-05 University Of South Florida SHIP-deficiency to increase megakaryocyte progenitor production
US7763592B1 (en) 2003-11-20 2010-07-27 University Of South Florida SHIP-deficiency to increase megakaryocyte progenitor production
US20070082845A1 (en) * 2005-07-15 2007-04-12 The Penn State Research Foundation Ferritin as a therapeutic target in abnormal cells
EP2046954A2 (de) 2006-07-31 2009-04-15 Curevac GmbH Nukleinsäure der formel (i): gixngn, oder (ii): cixmcn, insbesondere als immunstimulierendes mittel/adjuvans
WO2009030254A1 (en) 2007-09-04 2009-03-12 Curevac Gmbh Complexes of rna and cationic peptides for transfection and for immunostimulation
CA2710534C (en) 2008-01-31 2018-09-04 Curevac Gmbh Nucleic acids of formula (i) (nuglxmgnnv)a and derivatives thereof as an immunostimulating agent/adjuvant
WO2010037408A1 (en) 2008-09-30 2010-04-08 Curevac Gmbh Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
US20110053829A1 (en) 2009-09-03 2011-03-03 Curevac Gmbh Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
JP5948327B2 (ja) 2010-07-30 2016-07-06 キュアヴァック アーゲー トランスフェクションおよび免疫刺激のためのジスルフィド架橋されたカチオン性成分との核酸の複合体形成
WO2013113326A1 (en) 2012-01-31 2013-08-08 Curevac Gmbh Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen
US9738706B2 (en) * 2013-03-22 2017-08-22 University Of South Florida Inflammatory disease diagnosis and methods of treatment using lipopolysaccharides-responsive beige-like anchor
SG11201510746WA (en) 2013-08-21 2016-03-30 Curevac Ag Respiratory syncytial virus (rsv) vaccine
WO2015149944A2 (en) 2014-04-01 2015-10-08 Curevac Gmbh Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvant
US9974290B2 (en) 2015-04-17 2018-05-22 University Of South Florida Animal model and method for studying gene-gene interactions
CN105238875A (zh) * 2015-11-19 2016-01-13 湖南宏雅基因技术有限公司 基于lrba基因检测抗ctla-4抗体药物疗效的试剂盒
WO2024226391A1 (en) * 2023-04-24 2024-10-31 The Trustees Of The University Of Pennsylvania Synthetic variants of antimicrobial peptides

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5614395A (en) 1988-03-08 1997-03-25 Ciba-Geigy Corporation Chemically regulatable and anti-pathogenic DNA sequences and uses thereof
US5789214A (en) 1988-03-08 1998-08-04 Novartis Finance Corporation Method of inducing gene transcription in a plant
US5639949A (en) 1990-08-20 1997-06-17 Ciba-Geigy Corporation Genes for the synthesis of antipathogenic substances
ATE191931T1 (de) 1990-11-23 2000-05-15 Plant Genetic Systems Nv Verfahren zur transformation monokotyler pflanzen
US5593874A (en) 1992-03-19 1997-01-14 Monsanto Company Enhanced expression in plants
US5693512A (en) 1996-03-01 1997-12-02 The Ohio State Research Foundation Method for transforming plant tissue by sonication
CA2443338A1 (en) * 2001-04-02 2002-10-10 University Of South Florida Lps-responsive chs1/beige-like anchor gene and therapeutic applications thereof
US8440395B2 (en) * 2001-04-02 2013-05-14 University Of South Florida Methods of detecting and treating colon disorders
US20110165566A1 (en) * 2009-07-09 2011-07-07 Wittliff James L Methods of optimizing treatment of breast cancer

Also Published As

Publication number Publication date
CA2443338A1 (en) 2002-10-10
WO2002078614A2 (en) 2002-10-10
US20100266548A1 (en) 2010-10-21
US20040235765A1 (en) 2004-11-25
WO2002078614A3 (en) 2003-03-20
DE60235297D1 (de) 2010-03-25
EP1383924B1 (de) 2010-02-10
US7704963B2 (en) 2010-04-27
EP1383924A2 (de) 2004-01-28
EP1383924A4 (de) 2005-06-15
AU2002303214A1 (en) 2002-10-15

Similar Documents

Publication Publication Date Title
ATE457359T1 (de) Auf lps-reagierendes chs1/beige-ähnliches anker- gen und therapeutische anwendungen davon
ATE435923T1 (de) Neue polynukleotide und polypeptide des erythropoietingens
EP2258383A3 (de) Von der Telomerase abgeleitete antigene Peptide
WO2004043382A3 (en) Enhanced variants of erythropoietin and methods of use
WO2002072788A3 (en) Chronic obstructive pulmonary disease-related immunglobulin derived proteins, compositions, methods and uses
WO2003014307A3 (en) Antisense modulation of apolipoprotein(a) expression
WO2003013535A3 (en) Use of irinotecan for improved treatment of cancer based on mdr1
WO1999053040A3 (de) Menschliche nukleinsäuresequenzen aus ovartumorgewebe
WO2003048315A3 (en) Antisense modulation of mdm2 expression
IL158415A0 (en) NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNalpha-17 GENE
WO2004076614A3 (de) Humane nukleinsäuresequenzen aus prostatakarzinomen
WO1999046374A3 (de) Menschliche nukleinsäuresequenzen aus prostatatumorgewebe
IL207012A (en) 28sgp medicinal product and 28sgp accent cancer treatment vaccine
WO2003000896A3 (en) POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-5 GENE
WO1999046375A3 (de) Menschliche nukleinsäuresequenzen aus prostatagewebe
WO2003050247A3 (en) Antisense modulation of mhc class ii transactivator expression
WO2002060476A3 (de) Tumorvakzine
WO2003027229A3 (en) Antisense modulation of rip2 expression
WO2002083733A3 (en) Polynucleotides and polypeptides of the ifnalpha-6 gene
DE60222669D1 (de) Asthma-assoziiertes gen
ATE328082T1 (de) Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen
GB0228441D0 (en) Splice variant
WO2004089980A3 (en) Therapeutic cancer vaccine
WO2005049818A3 (en) Genes encoding human deubiquitinating enzymes
AU2003300224A8 (en) Use of the multifunctional transcription factor yin-yang-1 and variants thereof for treating illnesses, especially type 1 diabetes

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties